Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors

M Ahmadi, S Bekeschus, KD Weltmann… - RSC Medicinal …, 2022 - pubs.rsc.org
Cyclooxygenase (COX) enzymes comprise COX-1 and COX-2 isoforms and are responsible
for prostaglandin production. Prostaglandins have critical roles in the inflammation pathway …

Niclosamide: Beyond an antihelminthic drug

W Chen, RA Mook Jr, RT Premont, J Wang - Cellular signalling, 2018 - Elsevier
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of
people worldwide. However recent studies have indicated that niclosamide may have broad …

Nanoparticles and targeted drug delivery in cancer therapy

B Bahrami, M Hojjat-Farsangi, H Mohammadi… - Immunology letters, 2017 - Elsevier
Surgery, chemotherapy, radiotherapy, and hormone therapy are the main common anti-
tumor therapeutic approaches. However, the non-specific targeting of cancer cells has made …

Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non–small cell lung cancer

R Li, Z Hu, SY Sun, ZG Chen, TK Owonikoko… - Molecular cancer …, 2013 - AACR
The emergence of resistance to EGF receptor (EGFR) inhibitor therapy is a major clinical
problem for patients with non–small cell lung cancer (NSCLC). The mechanisms underlying …

EGF receptor-targeted nanocarriers for enhanced cancer treatment

AM Master, A Sen Gupta - Nanomedicine, 2012 - Taylor & Francis
The 'nanomedicine'approach has revolutionized cancer therapy by enabling the packaging
of therapeutic agents within engineered nanovehicles that can specifically accumulate …

Resistance to epigenetic-targeted therapy engenders tumor cell vulnerabilities associated with enhancer remodeling

AB Iniguez, G Alexe, EJ Wang, G Roti, S Patel, L Chen… - Cancer Cell, 2018 - cell.com
Drug resistance represents a major challenge to achieving durable responses to cancer
therapeutics. Resistance mechanisms to epigenetically targeted drugs remain largely …

Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide …

T Goldkorn, S Filosto, S Chung - Antioxidants & redox signaling, 2014 - liebertpub.com
Chronic obstructive pulmonary disease (COPD) and lung cancer are frequently caused by
tobacco smoking. However, these diseases present opposite phenotypes involving redox …

Tumor control versus adverse events with targeted anticancer therapies

DMK Keefe, EH Bateman - Nature reviews Clinical oncology, 2012 - nature.com
The advent of targeted anticancer therapies over the past few decades has reinvigorated the
field of cancer therapeutics, with the promise of increased cancer cure rates accompanied …

The role of vasopressin V2 receptor in drug-induced hyponatremia

S Kim, CH Jo, GH Kim - Frontiers in physiology, 2021 - frontiersin.org
Hyponatremia is frequently encountered in clinical practice and usually induced by renal
water retention. Many medications are considered to be among the various causes of …

Nanoparticles for cancer therapy using magnetic forces

R Tietze, S Lyer, S Dürr, C Alexiou - Nanomedicine, 2012 - Taylor & Francis
The term 'nanomedicine'refers to the use of nanotechnology in the treatment, diagnosis and
monitoring of diseases. Magnetic drug targeting is a particularly promising application in this …